Advertisement
Advertisement
TELO
Telomir Pharmaceuticals, Inc. Common Stock
1.30
USDSponsored
-0.02
-1.52%
May 08, 15:59 UTC -4
Closed
After-Market
1.34
+0.04
+3.38%
TELO Earnings Reports
Positive Surprise Ratio
TELO beat 2 of 5 last estimates.
40%
Next Report
In 2 Days
Date of Next Report
May 12, 2026
Estimate for Q1 26 (Revenue/ EPS)
--
/-$0.07
Implied change from Q4 25 (Revenue/ EPS)
--
/-75.00%
Implied change from Q1 25 (Revenue/ EPS)
--
/--
Telomir Pharmaceuticals, Inc. Common Stock earnings per share and revenue
On Mar 17, 2026, TELO reported earnings of -0.28 USD per share (EPS) for Q4 25, missing the estimate of -0.07 USD, resulting in a -292.16% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -5.93% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 3 analysts forecast an EPS of -0.07 USD, with revenue projected to reach -- USD, implying an decrease of -75.00% EPS, and increase of 0.00% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Quoin Pharmaceuticals, Ltd. - ADR
Report Date
May 07, 2026 For Q1 26
Estimate
-$1.96
Actual
-$1.77
Surprise
+9.93%
ZOETIS INC.
Report Date
May 07, 2026 For Q1 26
Estimate
$1.63
Actual
$1.53
Surprise
-6.19%
Stevanato Group S.p.A.
Report Date
May 07, 2026 For Q1 26
Estimate
$0.10
Actual
$0.11
Surprise
+5.45%
Crinetics Pharmaceuticals, Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
-$1.26
Actual
-$1.23
Surprise
+2.51%
NewAmsterdam Pharma Company N.V. Ordinary Shares
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.50
Actual
-$0.40
Surprise
+20.32%
Collegium Pharmaceutical, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
$1.62
Actual
$1.76
Surprise
+8.43%
Xeris Biopharma Holdings, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
$0.00
Actual
$0.01
Surprise
+296.08%
Ironwood Pharmaceuticals, Inc. - Class A
Report Date
May 07, 2026 For Q1 26
Estimate
$0.24
Actual
$0.24
Surprise
-1.96%
SIGA Technologies Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
-Actual
-$0.05
Surprise
-
Profound Medical Corp. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.25
Actual
-$0.19
Surprise
+25.75%
FAQ
What were Telomir Pharmaceuticals, Inc. Common Stock's earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Telomir Pharmaceuticals, Inc. Common Stock reported EPS of -$0.28, missing estimates by -292.16%, and revenue of $0.00, 0% as expectations.
How did the market react to Telomir Pharmaceuticals, Inc. Common Stock's Q4 2025 earnings?
The stock price moved down -5.93%, changed from $1.35 before the earnings release to $1.27 the day after.
When is Telomir Pharmaceuticals, Inc. Common Stock expected to report next?
The next earning report is scheduled for May 12, 2026.
What are the forecasts for Telomir Pharmaceuticals, Inc. Common Stock's next earnings report?
Based on 3
analysts, Telomir Pharmaceuticals, Inc. Common Stock is expected to report EPS of -$0.07 and revenue of -- for Q1 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement